Hair Repigmentation Associated With the Use of Brentuximab

    November 2017 in “ JAAD Case Reports ”
    Lauren R. Penzi, Athena Manatis-Lornell, Arturo P. Saavedra … Maryanne M. Senna
    Studysummary This study reports no known changes in hair pigmentation associated with brentuximab vedotin, despite its various other documented adverse effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadcasereports.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Repigmentation of Hair Following Adalimumab Therapy Dermatology online journal · 2015
    2. Hair Repigmentation Associated with the Use of Lenalidomide: Graying May Not Be an Irreversible Process Journal of oncology pharmacy practice · 2012
    3. The Cell Biology of Human Hair Follicle Pigmentation Pigment cell & melanoma research · 2010
    4. Aging of the Hair Follicle Pigmentation System International journal of trichology · 2009